Quick Answer
PHIBRO ANIMAL HEALTH CORP reported Total Revenue of $1.30 billion for fiscal year 2025.
PHIBRO ANIMAL HEALTH CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.30B +27.4% |
$1.02B +4.1% |
$977.89M +3.8% |
$942.26M +13.1% |
$833.35M +4.1% |
$800.35M -3.3% |
| Revenue (ASC 606) | $1.30B +27.4% |
$1.02B +4.1% |
$977.89M +3.8% |
$942.26M +13.1% |
$833.35M +4.1% |
$800.35M |
| Net Income | $48.26M +1897.7% |
$2.42M -92.6% |
$32.61M -33.7% |
$49.17M -9.6% |
$54.38M +62.1% |
$33.55M -38.7% |
| Diluted EPS | $1.19 +1883.3% |
$0.06 -92.6% |
$0.81 -33.1% |
$1.21 -9.7% |
$1.34 +61.4% |
$0.83 -38.5% |
| Total Assets | $1.36B +38.6% |
$982.18M +1.1% |
$971.40M +4.3% |
$931.70M +10.7% |
$841.33M +7.3% |
$784.10M +7.9% |
| Cash and Equivalents | $68.04M -3.6% |
$70.61M +71.1% |
$41.28M -44.4% |
$74.25M +47.9% |
$50.21M +38.2% |
$36.34M -36.9% |
| Stockholders Equity | $285.68M +11.3% |
$256.64M -9.2% |
$282.51M +7.6% |
$262.44M +10.0% |
$238.53M +26.7% |
$188.20M -12.9% |
| Operating Income | $110.47M +107.2% |
$53.31M -25.8% |
$71.85M -9.0% |
$78.99M +5.5% |
$74.87M +8.2% |
$69.19M -16.9% |
| Gross Profit | $399.94M +27.7% |
$313.09M +5.0% |
$298.24M +4.5% |
$285.40M +5.2% |
$271.38M +5.6% |
$256.88M -2.9% |
| Shares Outstanding | — | — | — | — | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2025 | $373.91M | +20.9% | +2.8% |
| Revenue (ASC 606) | December 31, 2025 | $373.91M | +20.9% | +2.8% |
| Net Income | December 31, 2025 | $27.46M | +762.1% | +3.5% |
| Diluted EPS | December 31, 2025 | $0.67 | +737.5% | +3.1% |
| Total Assets | December 31, 2025 | $1.41B | +9.3% | +1.4% |
| Cash and Equivalents | December 31, 2025 | $55.49M | -17.3% | -23.8% |
| Long-Term Debt | March 31, 2014 | $297.93M | — | +0.1% |
| Stockholders Equity | December 31, 2025 | $332.36M | +34.7% | +6.6% |
| Operating Income | December 31, 2025 | $50.33M | +97.1% | -1.8% |
| Gross Profit | December 31, 2025 | $132.66M | +30.2% | +10.7% |
| Shares Outstanding | March 31, 2014 | 68.91M | — | +0.0% |
- PHIBRO ANIMAL HEALTH CORP reported Total Revenue of $1.30 billion for fiscal year 2025.
- PHIBRO ANIMAL HEALTH CORP showed an increase of +27.4% in Total Revenue compared to the prior fiscal year.
- PHIBRO ANIMAL HEALTH CORP reported Revenue (ASC 606) of $1.30 billion for fiscal year 2025.
- PHIBRO ANIMAL HEALTH CORP showed an increase of +27.4% in Revenue (ASC 606) compared to the prior fiscal year.
- PHIBRO ANIMAL HEALTH CORP reported Net Income of $48.26 million for fiscal year 2025.
- PHIBRO ANIMAL HEALTH CORP showed an increase of +1897.7% in Net Income compared to the prior fiscal year.
- PHIBRO ANIMAL HEALTH CORP reported Diluted EPS of $1.19 per share for fiscal year 2025.
- PHIBRO ANIMAL HEALTH CORP showed an increase of +1883.3% in Diluted EPS compared to the prior fiscal year.
- PHIBRO ANIMAL HEALTH CORP reported Total Assets of $1.36 billion for fiscal year 2025.
- PHIBRO ANIMAL HEALTH CORP showed an increase of +38.6% in Total Assets compared to the prior fiscal year.
- PHIBRO ANIMAL HEALTH CORP reported Cash and Equivalents of $68.04 million for fiscal year 2025.
- PHIBRO ANIMAL HEALTH CORP showed a decrease of -3.6% in Cash and Equivalents compared to the prior fiscal year.
- PHIBRO ANIMAL HEALTH CORP reported Stockholders Equity of $285.68 million for fiscal year 2025.
- PHIBRO ANIMAL HEALTH CORP showed an increase of +11.3% in Stockholders Equity compared to the prior fiscal year.
- PHIBRO ANIMAL HEALTH CORP reported Operating Income of $110.47 million for fiscal year 2025.
- PHIBRO ANIMAL HEALTH CORP showed an increase of +107.2% in Operating Income compared to the prior fiscal year.
- PHIBRO ANIMAL HEALTH CORP reported Gross Profit of $399.94 million for fiscal year 2025.
- PHIBRO ANIMAL HEALTH CORP showed an increase of +27.7% in Gross Profit compared to the prior fiscal year.
- PHIBRO ANIMAL HEALTH CORP reported Shares Outstanding of 30.46 million shares for fiscal year 2013.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: